SCHEMBL18015402

SCHEMBL18015402

OCc1ccc(-c2ccc(Br)cn2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.53
▸ RAB9A P51151 4/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.53
▸ NFKB1 P19838 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ NFKB2 Q00653 1/20 0.53
▸ RELA Q04206 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ KDM1A O60341 1/20 0.53
▸ FYN P06241 10/20 0.47
▸ TP53 P04637 2/20 0.46
▸ THRB P10828 1/20 0.43
▸ CHEK1 O14757 1/20 0.42
▸ CHEK2 O96017 1/20 0.42
▸ ABL1 P00519 1/20 0.42
▸ MKNK1 Q9BUB5 1/20 0.41
▸ MKNK2 Q9HBH9 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ STAT3 P40763 1/20 0.40
▸ ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12002675 0.89 NPC1 (0.61) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL19933574 0.84 NPC1 (0.52) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL1416706 0.82 NPC1 (0.55) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL27618211 0.81 NPC1 (0.53) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL27635243 0.81 RAB9A (0.49) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL15132640 0.80 FYN (0.52) FYNCHEK1CHEK2
SCHEMBL386532 0.79 MEN1 (0.53) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL17954213 0.78 SMN1; SMN2 (0.66) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL12970151 0.78 KDM1A (0.53) NPC1RAB9ASMN1; SMN2KDM1AFYN
SCHEMBL12970398 0.78 CCR1 (0.54) NPC1RAB9ASMN1; SMN2NFKB1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 — — US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 — — EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 — — US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 — — US disclosed
WO-2016124304-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-08-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC NPC1 4039/4885RAB9A 2171/4885SMN1; SMN2 4799/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 NPC1 2761/4885RAB9A 1433/4885SMN1; SMN2 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback